Sclerotic-type chronic graft-versus-host disease exhibits activation of Th1 and OX40 cytokines. Kim M, Renert-Yuval Y, Stepensky P, Even-Or E, et al. J Invest Dermatol 2023 Sep 22:S0022-202X(23)02595.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim M, Renert-Yuval Y, Stepensky P, Even-Or E, et al. Sclerotic-type chronic graft-versus-host disease exhibits activation of Th1 and OX40 cytokines. J Invest Dermatol 2023 Sep 22:S0022-202X(23)02595.
PMID: 37742913